Home › Premarket Biotech Digest: Gilead's Genvoya, Avelumab Granted ODD, Bellerophon Rallies
 

Keywords :   


Premarket Biotech Digest: Gilead's Genvoya, Avelumab Granted ODD, Bellerophon Rallies

2015-09-28 17:27:51| Biotech - Topix.net

Breast cancer is not a single disease, but literally more than a hundred types of diseases and conditions. Breast cancer varies so much because it can be caused by more than one type of cell in the breast.

Tags: granted odd digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »